关于用于临床疼痛研究的迷幻药的伦理考虑
Christopher L Robinson1, Matthew Slitzky2, Michael E Schatman3,4
1Department of Anesthesiology, Perioperative & Pain Medicine, Harvard Medical School, Brigham & Women's Hospital, Boston, MA, USA.
Journal of pain research
|December 23, 2024
概括
迷幻药在治疗慢性疼痛方面表现有前途,在其他治疗方法失败的地方提供新的希望. 以自主性和公益性等原则为指导的伦理研究对于患者安全和负责任的科学进步至关重要.
科学领域:
- 精神病学和疼痛管理
- 神经科学和药理学 神经科学和药理学
背景情况:
- 过去用于医疗目的的迷幻药在精神病学研究中越来越受欢迎.
- 尽管该药物被列在"附表I"中,但新的证据表明它具有治疗潜力,特别是在治疗耐药性抑郁症中.
- 慢性疼痛影响数以百万计的人,而非阿片类药物选择有限,这促使人们开始探索迷幻药作为新型治疗方法.
研究的目的:
- 探索迷幻药物作为慢性疼痛的替代治疗方式的潜力.
- 解决用于疼痛管理的迷幻药研究中的伦理考虑和监管挑战.
- 倡导以原则为基础的研究伦理,以指导负责任的迷幻研究.
主要方法:
- 关于精神病学和疼痛管理中的迷幻药物的当前临床研究的综述.
- 对心理学研究应用的伦理原则 (自主,公益,正义,非恶性) 的分析.
- 审查监管格局 (FDA,DEA) 影响迷幻药物开发.
主要成果:
- 迷幻药对耐火抑郁症等疾病具有潜在的治疗益处.
- 伦理方面的挑战包括保护弱势群体和应对复杂的法规.
- 患者,研究人员和监管机构之间的透明合作是必不可少的.
结论:
- 精心规划和遵守伦理原则对于负责任的心理研究在慢性疼痛中至关重要.
- 将治疗承诺与伦理诚信相平衡,对于患者的福祉至关重要.
- 基于原则的伦理学可以指导利益相关者安全有效地推进迷幻研究.
相关概念视频
Psychosurgery
44
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
44
Hallucinogens and Psychedelics
156
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
156
Analgesia and Pain Management
496
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
496
CNS Stimulants: Psychedelic Agents
124
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
124
Ethics in Research
22.9K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
22.9K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
219
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
219


